EssilorLuxottica: UBS still on hold

(CercleFinance.com) - The analyst believes that Q1 sales growth is broadly in line with expectations, with currencies and North America likely to be the focus of concern.


UBS reiterates its neutral recommendation on the stock, with a target price of E181, representing 12% downside potential.

The group's total Q1 sales of E6,335m came in 1% below consensus (in line with the UBS estimate), with Q1 growth of +5.5% (vs. +5.8% for consensus and +5.5% for UBSe). Professional Solutions Q1 sales rose 4.6% (vs. +5.6%), according to UBS.


Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.